▶ 調査レポート

生物製剤安全性試験の世界市場(~2026年)

• 英文タイトル:Global Biologics Safety Testing Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。生物製剤安全性試験の世界市場(~2026年) / Global Biologics Safety Testing Market Size, Status and Forecast 2020-2026 / MRC2-11QY11074資料のイメージです。• レポートコード:MRC2-11QY11074
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は生物製剤安全性試験のグローバル市場について調査・分析したレポートです。種類別(エンドトキシン試験、無菌試験、細胞株認証・特性試験、生体負荷試験、細胞株認証、残留宿主汚染物質検出試験、外来剤検出試験、その他)市場規模、用途別(ワクチン開発、血液製剤検査、細胞・遺伝子治療、組織・組織関連製品検査、幹細胞研究)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別生物製剤安全性試験の競争状況、市場シェア
・世界の生物製剤安全性試験市場:種類別市場規模 2015年-2020年(エンドトキシン試験、無菌試験、細胞株認証・特性試験、生体負荷試験、細胞株認証、残留宿主汚染物質検出試験、外来剤検出試験、その他)
・世界の生物製剤安全性試験市場:種類別市場規模予測 2021年-2026年(エンドトキシン試験、無菌試験、細胞株認証・特性試験、生体負荷試験、細胞株認証、残留宿主汚染物質検出試験、外来剤検出試験、その他)
・世界の生物製剤安全性試験市場:用途別市場規模 2015年-2020年(ワクチン開発、血液製剤検査、細胞・遺伝子治療、組織・組織関連製品検査、幹細胞研究)
・世界の生物製剤安全性試験市場:用途別市場規模予測 2021年-2026年(ワクチン開発、血液製剤検査、細胞・遺伝子治療、組織・組織関連製品検査、幹細胞研究)
・北米の生物製剤安全性試験市場分析:米国、カナダ
・ヨーロッパの生物製剤安全性試験市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの生物製剤安全性試験市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の生物製剤安全性試験市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの生物製剤安全性試験市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Lonza Group、Charles River、Merck、SGS、WuXi AppTec、Thermo Fisher Scientific、Sartorius、Cytovance Biologics、Pace Analytical Services、Toxikon
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.

Market Analysis and Insights: Global Biologics Safety Testing Market
The global Biologics Safety Testing market size is projected to reach US$ 2653.5 million by 2026, from US$ 2467.4 million in 2020, at a CAGR of 7.0%% during 2021-2026.

Global Biologics Safety Testing Scope and Market Size
Biologics Safety Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Safety Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon

Market segment by Type, the product can be split into
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Market segment by Application, split into
Vaccine Development
Blood Products Testing
Cellular & Gene Therapy
Tissue and Tissue-Related Products Testing
Stem Cell Research

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Safety Testing Revenue
1.4 Market by Type
1.4.1 Global Biologics Safety Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Endotoxin Tests
1.4.3 Sterility Tests
1.4.4 Cell Line Authentication and Characterization Tests
1.4.5 Bioburden Tests
1.4.6 Cell Line Authentication
1.4.7 Residual Host Contaminant Detection Tests
1.4.8 Adventitious Agent Detection Tests
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biologics Safety Testing Market Share by Application: 2020 VS 2026
1.5.2 Vaccine Development
1.5.3 Blood Products Testing
1.5.4 Cellular & Gene Therapy
1.5.5 Tissue and Tissue-Related Products Testing
1.5.6 Stem Cell Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Biologics Safety Testing Market Perspective (2015-2026)
2.2 Global Biologics Safety Testing Growth Trends by Regions
2.2.1 Biologics Safety Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologics Safety Testing Historic Market Share by Regions (2015-2020)
2.2.3 Biologics Safety Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologics Safety Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Biologics Safety Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Biologics Safety Testing Players by Market Size
3.1.1 Global Top Biologics Safety Testing Players by Revenue (2015-2020)
3.1.2 Global Biologics Safety Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologics Safety Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologics Safety Testing Market Concentration Ratio
3.2.1 Global Biologics Safety Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologics Safety Testing Revenue in 2019
3.3 Biologics Safety Testing Key Players Head office and Area Served
3.4 Key Players Biologics Safety Testing Product Solution and Service
3.5 Date of Enter into Biologics Safety Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biologics Safety Testing Historic Market Size by Type (2015-2020)
4.2 Global Biologics Safety Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Biologics Safety Testing Market Size by Application (2015-2020)
5.2 Global Biologics Safety Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Biologics Safety Testing Market Size (2015-2020)
6.2 Biologics Safety Testing Key Players in North America (2019-2020)
6.3 North America Biologics Safety Testing Market Size by Type (2015-2020)
6.4 North America Biologics Safety Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Biologics Safety Testing Market Size (2015-2020)
7.2 Biologics Safety Testing Key Players in Europe (2019-2020)
7.3 Europe Biologics Safety Testing Market Size by Type (2015-2020)
7.4 Europe Biologics Safety Testing Market Size by Application (2015-2020)

8 China
8.1 China Biologics Safety Testing Market Size (2015-2020)
8.2 Biologics Safety Testing Key Players in China (2019-2020)
8.3 China Biologics Safety Testing Market Size by Type (2015-2020)
8.4 China Biologics Safety Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Biologics Safety Testing Market Size (2015-2020)
9.2 Biologics Safety Testing Key Players in Japan (2019-2020)
9.3 Japan Biologics Safety Testing Market Size by Type (2015-2020)
9.4 Japan Biologics Safety Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Biologics Safety Testing Market Size (2015-2020)
10.2 Biologics Safety Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologics Safety Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Biologics Safety Testing Market Size by Application (2015-2020)

11 India
11.1 India Biologics Safety Testing Market Size (2015-2020)
11.2 Biologics Safety Testing Key Players in India (2019-2020)
11.3 India Biologics Safety Testing Market Size by Type (2015-2020)
11.4 India Biologics Safety Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Biologics Safety Testing Market Size (2015-2020)
12.2 Biologics Safety Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologics Safety Testing Market Size by Type (2015-2020)
12.4 Central & South America Biologics Safety Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Lonza Group
13.1.1 Lonza Group Company Details
13.1.2 Lonza Group Business Overview
13.1.3 Lonza Group Biologics Safety Testing Introduction
13.1.4 Lonza Group Revenue in Biologics Safety Testing Business (2015-2020))
13.1.5 Lonza Group Recent Development
13.2 Charles River
13.2.1 Charles River Company Details
13.2.2 Charles River Business Overview
13.2.3 Charles River Biologics Safety Testing Introduction
13.2.4 Charles River Revenue in Biologics Safety Testing Business (2015-2020)
13.2.5 Charles River Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Biologics Safety Testing Introduction
13.3.4 Merck Revenue in Biologics Safety Testing Business (2015-2020)
13.3.5 Merck Recent Development
13.4 SGS
13.4.1 SGS Company Details
13.4.2 SGS Business Overview
13.4.3 SGS Biologics Safety Testing Introduction
13.4.4 SGS Revenue in Biologics Safety Testing Business (2015-2020)
13.4.5 SGS Recent Development
13.5 WuXi AppTec
13.5.1 WuXi AppTec Company Details
13.5.2 WuXi AppTec Business Overview
13.5.3 WuXi AppTec Biologics Safety Testing Introduction
13.5.4 WuXi AppTec Revenue in Biologics Safety Testing Business (2015-2020)
13.5.5 WuXi AppTec Recent Development
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Details
13.6.2 Thermo Fisher Scientific Business Overview
13.6.3 Thermo Fisher Scientific Biologics Safety Testing Introduction
13.6.4 Thermo Fisher Scientific Revenue in Biologics Safety Testing Business (2015-2020)
13.6.5 Thermo Fisher Scientific Recent Development
13.7 Sartorius
13.7.1 Sartorius Company Details
13.7.2 Sartorius Business Overview
13.7.3 Sartorius Biologics Safety Testing Introduction
13.7.4 Sartorius Revenue in Biologics Safety Testing Business (2015-2020)
13.7.5 Sartorius Recent Development
13.8 Cytovance Biologics
13.8.1 Cytovance Biologics Company Details
13.8.2 Cytovance Biologics Business Overview
13.8.3 Cytovance Biologics Biologics Safety Testing Introduction
13.8.4 Cytovance Biologics Revenue in Biologics Safety Testing Business (2015-2020)
13.8.5 Cytovance Biologics Recent Development
13.9 Pace Analytical Services
13.9.1 Pace Analytical Services Company Details
13.9.2 Pace Analytical Services Business Overview
13.9.3 Pace Analytical Services Biologics Safety Testing Introduction
13.9.4 Pace Analytical Services Revenue in Biologics Safety Testing Business (2015-2020)
13.9.5 Pace Analytical Services Recent Development
13.10 Toxikon
13.10.1 Toxikon Company Details
13.10.2 Toxikon Business Overview
13.10.3 Toxikon Biologics Safety Testing Introduction
13.10.4 Toxikon Revenue in Biologics Safety Testing Business (2015-2020)
13.10.5 Toxikon Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Biologics Safety Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Biologics Safety Testing Revenue
Table 3. Ranking of Global Top Biologics Safety Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologics Safety Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Endotoxin Tests
Table 6. Key Players of Sterility Tests
Table 7. Key Players of Cell Line Authentication and Characterization Tests
Table 8. Key Players of Bioburden Tests
Table 9. Key Players of Cell Line Authentication
Table 10. Key Players of Residual Host Contaminant Detection Tests
Table 11. Key Players of Adventitious Agent Detection Tests
Table 12. Key Players of Others
Table 13. Global Biologics Safety Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Biologics Safety Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Biologics Safety Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Biologics Safety Testing Market Share by Regions (2015-2020)
Table 17. Global Biologics Safety Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Biologics Safety Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Biologics Safety Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Biologics Safety Testing Players
Table 24. Global Biologics Safety Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Biologics Safety Testing Market Share by Players (2015-2020)
Table 26. Global Top Biologics Safety Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Safety Testing as of 2019)
Table 27. Global Biologics Safety Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Biologics Safety Testing Product Solution and Service
Table 30. Date of Enter into Biologics Safety Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Biologics Safety Testing Market Size Share by Type (2015-2020)
Table 34. Global Biologics Safety Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Biologics Safety Testing Market Size Share by Application (2015-2020)
Table 36. Global Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Biologics Safety Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Biologics Safety Testing Market Share (2019-2020)
Table 40. North America Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Biologics Safety Testing Market Share by Type (2015-2020)
Table 42. North America Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Biologics Safety Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Biologics Safety Testing Market Share (2019-2020)
Table 46. Europe Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Biologics Safety Testing Market Share by Type (2015-2020)
Table 48. Europe Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Biologics Safety Testing Market Share by Application (2015-2020)
Table 50. China Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Biologics Safety Testing Market Share (2019-2020)
Table 52. China Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Biologics Safety Testing Market Share by Type (2015-2020)
Table 54. China Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Biologics Safety Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Biologics Safety Testing Market Share (2019-2020)
Table 58. Japan Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Biologics Safety Testing Market Share by Type (2015-2020)
Table 60. Japan Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Biologics Safety Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Biologics Safety Testing Market Share (2019-2020)
Table 64. Southeast Asia Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Biologics Safety Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Biologics Safety Testing Market Share by Application (2015-2020)
Table 68. India Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Biologics Safety Testing Market Share (2019-2020)
Table 70. India Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Biologics Safety Testing Market Share by Type (2015-2020)
Table 72. India Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Biologics Safety Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Biologics Safety Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Biologics Safety Testing Market Share (2019-2020)
Table 76. Central & South America Biologics Safety Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Biologics Safety Testing Market Share by Type (2015-2020)
Table 78. Central & South America Biologics Safety Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Biologics Safety Testing Market Share by Application (2015-2020)
Table 80. Lonza Group Company Details
Table 81. Lonza Group Business Overview
Table 82. Lonza Group Product
Table 83. Lonza Group Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 84. Lonza Group Recent Development
Table 85. Charles River Company Details
Table 86. Charles River Business Overview
Table 87. Charles River Product
Table 88. Charles River Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 89. Charles River Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. SGS Company Details
Table 96. SGS Business Overview
Table 97. SGS Product
Table 98. SGS Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 99. SGS Recent Development
Table 100. WuXi AppTec Company Details
Table 101. WuXi AppTec Business Overview
Table 102. WuXi AppTec Product
Table 103. WuXi AppTec Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 104. WuXi AppTec Recent Development
Table 105. Thermo Fisher Scientific Company Details
Table 106. Thermo Fisher Scientific Business Overview
Table 107. Thermo Fisher Scientific Product
Table 108. Thermo Fisher Scientific Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 109. Thermo Fisher Scientific Recent Development
Table 110. Sartorius Company Details
Table 111. Sartorius Business Overview
Table 112. Sartorius Product
Table 113. Sartorius Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 114. Sartorius Recent Development
Table 115. Cytovance Biologics Business Overview
Table 116. Cytovance Biologics Product
Table 117. Cytovance Biologics Company Details
Table 118. Cytovance Biologics Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 119. Cytovance Biologics Recent Development
Table 120. Pace Analytical Services Company Details
Table 121. Pace Analytical Services Business Overview
Table 122. Pace Analytical Services Product
Table 123. Pace Analytical Services Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 124. Pace Analytical Services Recent Development
Table 125. Toxikon Company Details
Table 126. Toxikon Business Overview
Table 127. Toxikon Product
Table 128. Toxikon Revenue in Biologics Safety Testing Business (2015-2020) (Million US$)
Table 129. Toxikon Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Safety Testing Market Share by Type: 2020 VS 2026
Figure 2. Endotoxin Tests Features
Figure 3. Sterility Tests Features
Figure 4. Cell Line Authentication and Characterization Tests Features
Figure 5. Bioburden Tests Features
Figure 6. Cell Line Authentication Features
Figure 7. Residual Host Contaminant Detection Tests Features
Figure 8. Adventitious Agent Detection Tests Features
Figure 9. Others Features
Figure 10. Global Biologics Safety Testing Market Share by Application: 2020 VS 2026
Figure 11. Vaccine Development Case Studies
Figure 12. Blood Products Testing Case Studies
Figure 13. Cellular & Gene Therapy Case Studies
Figure 14. Tissue and Tissue-Related Products Testing Case Studies
Figure 15. Stem Cell Research Case Studies
Figure 16. Biologics Safety Testing Report Years Considered
Figure 17. Global Biologics Safety Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Biologics Safety Testing Market Share by Regions: 2020 VS 2026
Figure 19. Global Biologics Safety Testing Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Biologics Safety Testing Market Share by Players in 2019
Figure 22. Global Top Biologics Safety Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Safety Testing as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Biologics Safety Testing Revenue in 2019
Figure 24. North America Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Biologics Safety Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed